SSP
DGX icon

Sapphire Star Partners’s Quest Diagnostics DGX Stock Holding History

Sapphire Star Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$70K Buy
+852
New +$79.9K 0.09% 96

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sapphire Star Partners's DGX Position: Q4 2018 in Review

Sapphire Star Partners opened a new position in Quest Diagnostics (DGX) in Q4 2018: 852 shares worth $70K. The stake represents 0.09% of the portfolio and ranks #96 among its holdings.

624 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

  • Sapphire Star Partners held 852 shares of Quest Diagnostics worth $70K as of Q4 2018.
  • Quest Diagnostics was a new Sapphire Star Partners position in Q4 2018.
  • Quest Diagnostics made up 0.09% of Sapphire Star Partners's portfolio in Q4 2018, its #96 holding.
  • 624 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.